Description

Digihaler FF 6/250 Inhaler is a combination inhaler containing:

• Formoterol (6mcg): A long-acting beta-2 agonist (LABA) that relaxes airway muscles, improving airflow and easing breathing.

• Fluticasone Propionate (250mcg): An inhaled corticosteroid (ICS) that reduces airway inflammation, swelling, and mucus production.

This dual-action formulation provides both rapid bronchodilation and long-term anti-inflammatory control, making it suitable for asthma management. The inhaler also features digital dose tracking, which helps patients and healthcare providers monitor adherence and optimize treatment outcomes.

---

Uses

• Maintenance therapy of asthma in adults and adolescents

• Prevention of asthma symptoms such as wheezing, breathlessness, and nighttime attacks

• Chronic management of COPD in patients with airway inflammation and frequent exacerbations

• Reduces the risk of asthma flare-ups and hospitalizations

---

Dosage & Directions for Use

• Standard adult dose: 1 inhalation twice daily, or as directed by your physician.

• Shake inhaler well before use.

• Exhale fully, place the mouthpiece in your mouth, and inhale slowly while pressing the canister.

• Hold your breath for 5–10 seconds, then exhale slowly.

• Rinse your mouth with water after each use to reduce the risk of oral thrush.

• Do not exceed the prescribed dose.

---

Possible Side Effects

Common:

• Tremors or shaking of hands

• Headache, dizziness

• Throat irritation, hoarseness, or mild cough

• Palpitations or mild rapid heartbeat

Rare but serious:

• Severe allergic reactions (rash, swelling, difficulty breathing)

• Oral or throat infections (thrush) due to corticosteroid use

• Paradoxical bronchospasm

• Significant heart rhythm disturbances

⚠️ Use cautiously in patients with heart disease, hypertension, or diabetes. Long-term monitoring may be required for chronic therapy.

---

About the Company – Glenmark Pharmaceuticals Ltd

Founded in 1977 in Mumbai, India, Glenmark Pharmaceuticals Ltd is a global pharmaceutical leader with expertise in respiratory care, dermatology, and oncology.

The Digihaler FF range provides effective asthma management by combining long-acting bronchodilators with corticosteroids, along with digital tracking technology to improve adherence, monitoring, and patient outcomes.